This document summarizes a study examining the mechanism of PDZK1 in hepatocellular carcinoma complicated with hyperuricemia. The study used flow cytometry, RT-PCR analysis, western blot assay, and in vivo tumorigenesis experiments to evaluate the expression of the PDZK1 protein in samples of hepatocellular carcinoma tissue from mice with induced hyperuricemia. The results suggest that high levels of uric acid may increase PDZK1 expression and affect proliferation, migration, and apoptosis of hepatocellular carcinoma by impacting tumor immunity. The conclusions indicate that further understanding protein interactions between diseases can reveal new treatment approaches.